Breast Cancer News: Breaking Breast Cancer News, Comments and Articles. - Page: 5

Explainer: what are stem cells?

By Merlin CrossleyIn a paper published in Cell yesterday, scientists from the US and Thailand have, for the first time, successfully produced embryonic stem cells from human skin cells.That sounds interesting, but what are stem cells and where do they come from?If you take a limb from a rose tree, and put it in soil, it will grow into a thriving bush.But you might say: “Plants are special. This...

Women In 40s Continue To Get Routine Mammograms At Same Rate, Despite New Recommendations

Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new Johns Hopkins research. In 2009, the U.S. Preventive Services Task Force (USPSTF) sifted through the evidence...

More than one-third of Texas women still receive unnecessary breast biopsy surgery

(University of Texas Medical Branch at Galveston) Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast a...

Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation

Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City

SAN FRANCISCO, May 16, 2013 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 2013 UBS Global Healthcare Conference in New York at the Sheraton New York Hotel on Tuesday, May 21, 2013 at 10:00 a.m. Eastern time. The presentation will be accessible via a Webcast through a link posted in the Inves...

Angelina Jolie's Mastectomy: BRCA Testing in the Spotlight

Superstar Angelina Jolie's headline revelation this week about her positive genetic test for the BRCA1 mutation and subsequent double prophylactic mastectomy has stunned the world and put the entire field of breast cancer medicine on high alert. Me...

Eisai Highlights New Research On Melanoma, Breast and Endometrial Cancer at ASCO Annual Meeting

WOODCLIFF LAKE, N.J., May 16, 2013 /PRNewswire/ -- Eisai Inc. announced today that nine abstracts highlighting new study results in melanoma, breast and endometrial cancer will be presented during the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago from May 31 - June 4, 2013. (Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO )...

Patients Honor Dr. Dino Elyassnia for Compassion

SAN FRANCISCO, May 16, 2013 /PRNewswire-USNewswire/ -- Patients' Choice has announced that Dr. Dino Elyassnia was one of a select few physicians honored with the prestigious 2012 Compassionate Doctor Certification. (Photo: http://photos.prnewswire.com/prnh/20130516/DC15689) Each year, nearly 100 million patients across the U.S. access websites like Vitals, UCompareHealthCare, and Patients' Cho...

The Brain Aneurysm Foundation Heads to Capitol Hill on May 21, 2013 for National Lobbying Effort

Organization and Supporters to Encourage Legislators to Support Funding for Brain Aneurysm Research and the Importance of Early Detection Screening. Hanover, MA (PRWEB) May 16, 2013 According to the Brain Aneurysm Foundation, it is estimated that more than 6 million people in the United States have an unruptured brain aneurysm. Although all aneurysms do not rupture during the course of a person�...

Doctors detail Angelina Jolie's breast surgery

Angelina Jolie's mother had breast cancer and died of ovarian cancer, and her maternal grandmother also had ovarian cancer — strong evidence of an inherited, genetic risk that led the actress to have both of her healthy breasts removed to try to avoid the sam …

Viewpoints: When A Doctor Should Keep Quiet; 2 Views Of Hospital Pricing; Stem Cell 'Snake Oil'

Los Angeles Times: For A Dying Patient, A Prescription Of Silence In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions. And with patients likely to die of their diseases, discussing the prognosis frankly would allow them...

Chronix Biomedical Announces Multiple Poster Presentations at ASCO 2013

Data Highlight Next-Generation Sequencing of Cell-Free DNA to Detect Minimal Residual Disease in a Variety of Cancers Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, announces that four research abstracts highlighting the Company’s cell-free DNA technology for real-time cancer detection will be presented at the American So...

Matrix-Bio Names Goonewardene to Board of Directors

Goonewardene is a leader in technology commercialization, business formation;serves on AMA Board of Trustees and Personalized Medicine Coalition Board of Directors Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has named Julie K. Goonewardene to its Board of Directors. Goonewa...

Jean LaMantia, Registered Dietitian, Cancer Survivor and Author Announces that Like Angelina Jolie, Others Can Take Preventative Measures to Reduce Cancer Risk

Jean LaMantia, Registered Dietitian, Cancer Survivor and Author of The Essential Cancer Treatment Nutrition Guide and Cookbook advises that women with and without the BRCA1 and BRCA2 gene mutations can all take preventative measures. Toronto, ON (PRWEB) May 16, 2013 While some women like Angelina Jolie are aware of their susceptibility to breast cancer and take action to prevent it, not all have...

In Patients with Early Breast Cancer, Intensity-Modulated Radiotherapy Reduces Side Effects

Intensity-modulated radiotherapy provides better results than conventional radiotherapy in patients with early breast cancer, according to new findings.

Christopher Radko Gallery Presents the 2013 Christopher Radko Charity Awareness Ornament Collection

Christopher Radko Gallery announces the 2013 Christopher Radko Charity Awareness Ornaments. An authorized Radko ornament retail specialist since 2004, Christopher Radko Gallery features the finest handcrafted glass Christmas ornaments available in store or online with free shipping on orders over $75. Duluth, Georgia (PRWEB) May 16, 2013 Christopher Radko Gallery, a leading retail specialist of C...

Angelina's Medical Choice -- How Young is “Too Young” to Take Drastic Measures? Expert Surgeon Dr. Lisa Cassileth Weighs in on KTLA & TMZ

Actress Angelina Jolie’s decision to undergo preventive surgery for breast cancer has sparked a frenzy of discussion regarding BRCA gene testing and the increasingly common preventive mastectomy. Did she make the right choice, and how young is “too young” to consider taking drastic action to avoid breast cancer? Beverly Hills, CA (PRWEB) May 16, 2013 The rate of women opting to undergo prev...

Period Vitamin for Post Menstrual Syndrome Relief, Not Just PMS: New Report from Period Vitamin Sheds Light on Often Ignored Post Menstrual Syndrome

Period Vitamin researchers’ report says as many as one-third of all women experience post menstrual syndrome during their reproductive years. Los Angeles, CA (PRWEB) May 16, 2013 PMS doesn’t just stand for Premenstrual Syndrome anymore, it can also stand for post menstrual syndrome, according to a new report from Period Vitamin researchers. Entitled, “What is Post Menstrual Syndrome Disorde...

Study underscores new paradigm in cancer therapy

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate...

Women in 40s continue to undergo routine breast cancer screenings despite new recommendations

Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new Johns Hopkins research.

[Articles] Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial

Our results raise the possibility of decreasing administration of zoledronic acid to a 12-weekly regimen to reduce exposure during the second year, while maintaining its therapeutic effects. However, the effects on N-terminal telopeptide should be in...

[Comment] Zooming in on the schedule of bone-modifying drugs

Debate surrounds the best duration and scheduling of treatment with bone-modifying drugs for patients with breast cancer who have bone metastases. The recommended doses for zoledronic acid and denosumab are specified in the prescribing information of...

Medigene publishes final results from phase II Investigator Initiated Trial of EndoTAG®-1 at ASCO 2013

Medigene AG / Medigene publishes final results from phase II Investigator Initiated Trial of EndoTAG®-1 at ASCO 2013 . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Efficacy study with 15 patients meets primary endpoint EndoTAG®-1 and paclitaxel combination show promising preliminary activity as preoperative treatment...

Alethia Biotherapeutics Announces the Issuance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT

MONTREAL, QUEBEC -- (Marketwired) -- 05/16/13 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today that the Company has been granted United States Patent No. 8,426,562 covering methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoti...

Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting

TUSTIN, CA -- (Marketwired) -- 05/16/13 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced the presentation of three clinical posters at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 31-June 4, 2013 in Chicago, Illinoi...